---
cssclasses:
- academia
title: Week 5 - Advanced Financial Analysis and Valuation
linter-yaml-title-alias: Week 5 - Advanced Financial Analysis and Valuation
tags:
- acquisition
- advanced_financial_analysis
- corporate_finance
- financial_reporting
- goodwill_accounting
- intangible_assets
- ma_valuation
- merger
- pharmaceutical_industry
- portfolio-optimization
- randd_accounting
aliases:
- Week Five - Advanced Financial Analysis
- Week 5 - Intangibles and M&A
- Week 5 - Pharmaceuticals and R&D
key_concepts:
- Acquisition accounting impacts
- Capitalization versus expensing
- Derivative securities
- Financial risk management
- IFRS versus US GAAP differences
- Intangible asset amortization
- M&A accounting and goodwill impairment
- Non-GAAP reporting metrics
- Pharmaceutical industry valuation
- Portfolio optimization
- Quantitative financial analysis
- R&D and intangibles accounting
- Risk assessment and mitigation
---

# Week 5 - Advanced Financial Analysis and Valuation
%% Begin Waypoint %%
- **Week 5**
	- Week 5 Accounting Recap- R&D, Intangibles, M&A & Goodwill
	- Week 5 Pharmaceuticals and Intangibles in Valuation
%% End Waypoint %%